European Parliament signs off on strengthening drug regulator's ability to tackle shortages

The European Parliament on Thursday endorsed a plan to increase the powers of the European Medicines Agency, which will be better equipped to monitor and mitigate shortages of drugs and medical devices. By a vote of 655 to 31, parliament signed...

Secondary patents prove to be key in biosimilar blocking strategies, researchers find

While the US biosimilars industry has generally been a disappointment since its inception, with FDA approving 33 biosimilars since 2015, just a fraction of those have immediately followed their approvals with launches. And more than a handful of...